ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

RELATED EXCIPIENT COMPANIES

4 Actylis, 1 Finar

relatedExcipients
4 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Solubilizers

excipientsByApplications
3 Parenteral
2 Solubilizers

MARKET PLACE

1 FDF Dossiers

marketPlace
1 FDF Dossiers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

5 RELATED EXCIPIENT COMPANIES

5EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 125602-71-3, Betotastine, 190786-43-7, (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid, Tau 284, Hyd2u48ias

Molecular Formula

C₂₁H₂₅ClN₂O₃

Molecular Weight

388.9 g/mol

InChI Key

YWGDOWXRIALTES-NRFANRHFSA-N

FDA UNII

HYD2U48IAS

Bepotastine is a Histamine-1 Receptor Antagonist.

1 2D Structure

Sb17504

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid

2.1.2 InChI

InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1

2.1.3 InChI Key

YWGDOWXRIALTES-NRFANRHFSA-N

2.1.4 Canonical SMILES

C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O

2.1.5 Isomeric SMILES

C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O

2.2 Other Identifiers

2.2.1 UNII

HYD2U48IAS

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (s)-4-(4-((4-chlorophenyl)(2-pyridil)methoxy)piperidino)butylic Acid Monobenzenesulfonate

2. Betotastine

3. Betotastine Besilate

4. Tau 284

5. Tau-284

2.3.2 Depositor-Supplied Synonyms

1. 125602-71-3

2. Betotastine

3. 190786-43-7

4. (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid

5. Tau 284

6. Hyd2u48ias

7. 4-((4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid

8. 1-piperidinebutanoicacid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-

9. 4-[4-[(s)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic Acid

10. (+)-(s)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric Acid

11. Chebi:71204

12. 1-piperidinebutanoic Acid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-

13. (+)-4-(((s)-p-chloro-alpha-2-pyridylbenzyl)oxy)-1-piperidinebutyric Acid

14. 4-[4-[(s)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-ium-1-yl]butanoate

15. (s)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric Acid

16. Bepotastine [inn]

17. Unii-hyd2u48ias

18. Bepotastine [usan:inn]

19. Bepotastina

20. Bepotastinum

21. Bepotastine [mi]

22. Bepotastine (usan/inn)

23. (s)-4-(4-((4-chlorophenyl)(2-pyridil)methoxy)piperidino)butylic Acid

24. Bepotastine [usan]

25. Bepotastine [vandf]

26. Bepotastine [mart.]

27. Schembl29459

28. Bepotastine [who-dd]

29. Gtpl7466

30. Chembl1201758

31. Dtxsid90904947

32. Tqp0323

33. Zinc602128

34. Cs-m1828

35. Cs-m1895

36. Hy-i0021

37. S5940

38. Akos015913983

39. Am84655

40. Ncgc00386356-02

41. Ncgc00386356-05

42. Ac-26366

43. As-72863

44. D09705

45. D72208

46. Ab01565803_02

47. J-519839

48. Q4890915

49. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)-methoxy]piperidino]butanoic Acid

50. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]-butanoic Acid

51. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic Acid

52. 1-piperidinebutanoic Acid, 4-((4-chlorophenyl)-2-pyridinylmethoxy)-

53. 1-piperidinebutyric Acid, (+)-4-(((s)-p-chloro-2-pyridylbenzyl)oxy)-

54. (+)-4-(((s)-p-chloro-.alpha.-2-pyridylbenzyl)oxy)-1-piperidinebutyric Acid

55. (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoicacid

56. 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid

57. 4-{4-[(s)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic Acid

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₅ClN₂O₃
Molecular Weight	388.9 g/mol
XLogP3	1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	8
Exact Mass	388.1553704 g/mol
Monoisotopic Mass	388.1553704 g/mol
Topological Polar Surface Area	62.7 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	449
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 FDA Pharmacological Classification

4.1.1 Active Moiety

BEPOTASTINE

4.1.2 FDA UNII

HYD2U48IAS

4.1.3 Pharmacological Classes

Established Pharmacologic Class [EPC] - Histamine-1 Receptor Antagonist

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

Solubilizers

Market Place

Do you need sourcing support? Ask us

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Sb17504 manufacturers, exporters & distributors on PharmaCompass

Sb17504

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

RELATED EXCIPIENT COMPANIES

4 Actylis

1 Finar

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Solubilizers

MARKET PLACE

1 FDF Dossiers

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

5 RELATED EXCIPIENT COMPANIES

5EXCIPIENTS BY APPLICATIONS

What are you looking for?